Worth Venture Partners
GOSS icon

Worth Venture Partners’s Gossamer Bio GOSS Stock Holding History

Worth Venture Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-312,724
Closed -$4.06M – 2
2026
Q2 		$4.12M Buy
+312,724
New +$6.98M 9.29% 3

Other funds holding GOSS

Context Capital Management
Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
MB Generational Wealth
MB Generational Wealth Spokane, Washington $196M AUM 14.53% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Worth Venture Partners's GOSS Position: Q3 2026 in Review

Worth Venture Partners sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 312,724 shares — an estimated $4.06M sold.

Worth Venture Partners first reported a position in GOSS in Q2 2026 and held it in 1 quarter. The position peaked at $4.12M in Q2 2026. 33 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • Worth Venture Partners reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • Worth Venture Partners sold 312,724 Gossamer Bio shares in Q3 2026, an estimated $4.06M.
  • Worth Venture Partners first reported a position in Gossamer Bio in Q2 2026 and held it in 1 quarter.
  • Worth Venture Partners's Gossamer Bio position peaked at $4.12M in Q2 2026.
  • 33 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on Worth Venture Partners's 13F filing for Q3 2026, filed 12 Nov 2026.